Literature DB >> 12429095

Structure of the DNA binding region of prospero reveals a novel homeo-prospero domain.

Jodi M Ryter1, Chris Q Doe, Brian W Matthews.   

Abstract

The Prospero transcription factor promotes neural differentiation in Drosophila, and its activity is tightly regulated by modulating its subcellular localization. Prospero is exported from the nucleus of neural precursors but imported into the nucleus of daughter cells, which is necessary for their proper differentiation. Prospero has a highly divergent putative homeodomain adjacent to a conserved Prospero domain; both are required for sequence-specific DNA binding. Here we show that the structure of these two regions consists of a single structural unit (a homeo-prospero domain), in which the Prospero domain region is in position to contribute to DNA binding and also to mask a defined nuclear export signal that is within the putative homeodomain region. We propose that the homeo-prospero domain coordinately regulates Prospero nuclear localization and DNA binding specificity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429095     DOI: 10.1016/s0969-2126(02)00883-3

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  18 in total

1.  Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain.

Authors:  Asokan Anbanandam; Diana C Albarado; Catherine T Nguyen; Georg Halder; Xiaolian Gao; Sudha Veeraraghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

2.  Dual roles for Prox1 in the regulation of the chicken betaB1-crystallin promoter.

Authors:  Xiaoren Chen; Jennifer R Taube; Vladimir I Simirskii; Tapan P Patel; Melinda K Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

3.  Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.

Authors:  Jay W Shin; Michael Min; Fréderic Larrieu-Lahargue; Xavier Canron; Rainer Kunstfeld; Lynh Nguyen; Janet E Henderson; Andreas Bikfalvi; Michael Detmar; Young-Kwon Hong
Journal:  Mol Biol Cell       Date:  2005-11-16       Impact factor: 4.138

Review 4.  Role of Transcriptional and Epigenetic Regulation in Lymphatic Endothelial Cell Development.

Authors:  Hyeonwoo La; Hyunjin Yoo; Young Bin Park; Nguyen Xuan Thang; Chanhyeok Park; Seonho Yoo; Hyeonji Lee; Youngsok Choi; Hyuk Song; Jeong Tae Do; Kwonho Hong
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

5.  A pathway for unicellular tube extension depending on the lymphatic vessel determinant Prox1 and on osmoregulation.

Authors:  Irina Kolotuev; Vincent Hyenne; Yannick Schwab; David Rodriguez; Michel Labouesse
Journal:  Nat Cell Biol       Date:  2013-01-20       Impact factor: 28.824

6.  An intronic enhancer regulates splicing of the twintron of Drosophila melanogaster prospero pre-mRNA by two different spliceosomes.

Authors:  Petra Scamborova; Anthony Wong; Joan A Steitz
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

7.  Drosophila hnRNP A1 homologs Hrp36/Hrp38 enhance U2-type versus U12-type splicing to regulate alternative splicing of the prospero twintron.

Authors:  Sumit Borah; Anthony C Wong; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

8.  Prox1 directly interacts with LSD1 and recruits the LSD1/NuRD complex to epigenetically co-repress CYP7A1 transcription.

Authors:  Huafang Ouyang; Yi Qin; Yanfeng Liu; Youhua Xie; Jing Liu
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

9.  Prox1 Facilitates Transfected CHO Cell Proliferation through Activation of the AKT Signaling Pathway.

Authors:  Shang-Zhi Xu
Journal:  Int J Biomed Sci       Date:  2010-03

10.  PCNA interacts with Prox1 and represses its transcriptional activity.

Authors:  Xiaoren Chen; Tapan P Patel; Vladimir I Simirskii; Melinda K Duncan
Journal:  Mol Vis       Date:  2008-11-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.